Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 856.50
-25.20 (-2.86%)
Apr 24, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 257.69 million as of April 24, 2026. Its market cap has decreased by -3.29% in one year.
Market Cap
257.69M
Enterprise Value
231.93M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
856.50
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 257.69M, a decrease of -78.63%. That is a compound annual growth rate of -29.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 257.69M | 41.42% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 108.98B |
| Danel (Adir Yeoshua) | 2.86B |
| Amal Holdings A.D. | 2.38B |
| BrainsWay | 1.93B |
| Ilex Medical | 631.01M |
| Novolog (Pharm-Up 1966) | 521.60M |
| Bonus BioGroup | 485.94M |
| Geffen Residence & Renewal | 257.44M |